Alpine Immune Sciences   Report issue

For profit Phase 1 Phase 2
Founded: Seattle WA United States (2015)

Organization Overview

First Clinical Trial
2019
NCT03748836
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Alpine Immune Sciences | Alpine Immune Sciences, Inc.